praluent

This is Why Amgen is Soaring

By Ben LevisohnInvestors love biotech stocks, but heading into July, Amgen (AMGN) was unloved, especially compared to its other biotech giants like Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD) and Biogen (BIIB). No longer. Shares of Amgen have jumped nearly 6% after reporting better than forecast earnings and raising its guidance. UBS analyst Matthew Roden has the details:
Amgen reported another strong […]

July 31, 2015 ByBen Levisohn biogen, biotechnology, drug, etf, gilead, ishares, praluent, regn Comments Off read more

Biotech Stock News (RXII)(REGN)(SNY)(ESPR)(ISIS)(BIIB) | CNA …

Rxi Pharmaceuticals (NASDAQ:RXII)On June 9, 2015 shares of Rxi Pharmaceuticals went up 6% after the company reported that two new key patents were given to the company for use with their self-delivering sd-rxRNA technology platform. The new patents establish a few new details that enhance upon the company’s prospects:First the new patent is for a chemical modification that allows for […]

June 16, 2015 ByTerry Chrisomalis biotech, business, company, MRK, nasdaq, praluent, sma, stock Comments Off read more